Attana participates in the Drug Discovery V-Forum
Attana will participate in the conference Drug Discovery V-Forum on April 21-22, 2021 to present the company and meet potential customers, strategic partners and investors. The conference will take place digitally and involve both Swedish and international participants.
Over 100 attendees will explore the latest trends and strategies within discovery research. The online event will be a mixture of on-demand and live sessions and the main focus for Attana will be to meet new customers and potential partners for strategic collaborations. The conference will highlight the challenges discovery pipelines have faced due to COVID-19 and put a spotlight on the adoption of technology to combat these. Attana’s presentation from the conference will afterwards be published on the Attana website.
A link to the conference can be found here.
For more information, please contact:
Teodor Aastrup, CEO
+46 (0)8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.
Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact firstname.lastname@example.org